CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $179K invested in Can-Fite BioPharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$31.9K
2
+$2.17K
3
+$1.22K

Top Sellers

1
-$795
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$87.5K
2
$47.5K
3
$31.9K
4
$7.95K
5
$1.48K
6
$1.47K
7
$1.22K
8
$140
9
$67